Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus
- Shirong Qiang
- , Yusuke Nakatsu
- , Yasuyuki Seno
- , Midori Fujishiro
- , Hideyuki Sakoda
- , Akifumi Kushiyama
- , Keiichi Mori
- , Yasuka Matsunaga
- , Takeshi Yamamotoya
- , Hideaki Kamata
- , Tomoichiro Asano
研究成果: ジャーナルへの寄稿 › 記事 › 査読
97
被引用数
(Scopus)